11C‐2β‐carbomethoxy‐3β‐(4‐fluorophenyl) tropane positron emission tomography (PET) imaging from case PD‐11 revealed a graded and asymmetrical reduction in dopamine transporter binding in the putamen, which was compatible with PD (Figure 3). Here, SLC6A3 is linked to Parkinson disease.